January 13, 2026

Select Medical Holdings Corp (SEM): Investor Outlook with 21.45% Potential Upside

Select Medical Holdings Corp (NYSE: SEM) is making waves in the healthcare sector, particularly in the medical care facilities industry. Based in the United States, this company is a prominent..

Enovis Corporation (ENOV) Stock Analysis: Exploring the 68.66% Potential Upside for This Medical Device Innovator

Enovis Corporation (NYSE: ENOV) is making waves in the healthcare sector, particularly in the medical devices industry. With a market capitalization of $1.54 billion, this Wilmington, Delaware-based company is carving..

Progyny, Inc. (PGNY) Stock Analysis: Analyst Consensus and Growth Potential in the Fertility Benefits Sector

Progyny, Inc. (NASDAQ: PGNY), a prominent player in the healthcare sector, is gaining substantial attention from investors, thanks largely to its innovative approach to fertility and family-building benefits. As a..

Twist Bioscience Corporation (TWST): Investor Outlook Reveals 16.9% Revenue Growth and Bullish Analyst Ratings

Twist Bioscience Corporation (NASDAQ: TWST), a pioneering entity in the healthcare sector focused on diagnostics and research, has captured investor attention with its robust revenue growth and favorable analyst ratings...

BGM Group Ltd. (BGM): Navigating the Challenges in the Healthcare Sector

BGM Group Ltd. (BGM), a prominent player in the healthcare sector, operates within the specialized and generic drug manufacturing industry in China. Despite its significant market capitalization of $770.39 million,..

Vericel Corporation (VCEL) Stock Analysis: Unveiling a 50% Upside in the Biotech Sector

Vericel Corporation (NASDAQ: VCEL), a prominent player in the biotechnology sector, has recently caught the attention of investors due to its promising potential upside of 50.31%, according to analyst ratings..

NewAmsterdam Pharma (NAMS) Stock Analysis: A Biotech with 46% Upside Potential

NewAmsterdam Pharma Company N.V. (NASDAQ: NAMS) is capturing investor attention with its promising pipeline and substantial upside potential. As a late-stage biopharmaceutical company based in Naarden, the Netherlands, its focus..

Concentra Group Holdings Parent (CON): Investor Outlook on 38% Potential Upside

Concentra Group Holdings Parent, Inc. (CON) is gaining significant attention from investors, particularly those interested in the healthcare sector. As a provider of essential occupational health services across the United..

LifeStance Health Group, Inc. (LFST) Stock Analysis: 19% Upside Potential and Strong Buy Ratings

LifeStance Health Group, Inc. (NASDAQ: LFST), a prominent player in the healthcare sector, is capturing investor attention with its robust growth prospects and a notable potential upside. Specializing in outpatient..

Apellis Pharmaceuticals (APLS) Stock Analysis: A 50% Upside Potential in the Biotech Sector

Apellis Pharmaceuticals, Inc. (NASDAQ: APLS), a key player in the biotechnology sector, presents a compelling opportunity for investors with its promising pipeline and strategic collaborations. With a market capitalization of..

Perrigo Company plc (PRGO) Stock Analysis: Exploring a 40.56% Upside Potential for Investors

Perrigo Company plc (NYSE: PRGO), a stalwart in the healthcare sector, primarily operates within the drug manufacturing space with a focus on both specialty and generic products. Headquartered in Dublin,..

CG Oncology, Inc. (CGON) Stock Analysis: Unveiling a Potential 42% Upside in the Biotech Space

CG Oncology, Inc. (NASDAQ: CGON) is drawing significant attention from the investment community, not only due to its promising pipeline in the oncology sector but also because of its robust..

Alvotech (ALVO) Stock Analysis: Unpacking a Potential 349.63% Upside

Alvotech (NASDAQ: ALVO), a Luxembourg-based healthcare company specializing in biosimilar medicines, is drawing significant investor attention due to its potential upside of 349.63%. With a market capitalization of $1.54 billion,..

QuidelOrtho Corporation (QDEL) Stock Analysis: Navigating Growth Challenges with an Eye on a 12.91% Upside

QuidelOrtho Corporation (NASDAQ: QDEL), a key player in the healthcare sector specializing in medical devices, offers a fascinating valuation narrative for investors intrigued by the intricacies of diagnostic testing solutions...

Belite Bio, Inc (BLTE) Stock Analysis: A Biotech Gem with 19.70% Upside Potential

Belite Bio, Inc (BLTE), a San Diego-based clinical-stage biopharmaceutical company, is capturing investor attention with its innovative approach to treating retinal degenerative eye diseases and other unmet medical needs. Operating..

Mirum Pharmaceuticals, Inc. (MIRM) Investor Outlook: Promising Upside with 47.2% Revenue Growth

Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM), a biopharmaceutical firm based in Foster City, California, is attracting significant interest from investors with its focus on developing groundbreaking therapies for rare and orphan..

Crinetics Pharmaceuticals, Inc. (CRNX) Stock Analysis: A 52.66% Potential Upside Beckons Investors

As the biotechnology sector continues to capture investor attention with its cutting-edge innovations and high-growth potential, Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) stands out with a compelling narrative. The San Diego-based..

Warby Parker Inc. (WRBY) Stock Analysis: Revenue Growth and Analyst Confidence Signal Potential for Investors

Warby Parker Inc. (NYSE: WRBY) is capturing investor attention in the healthcare sector, specifically within the medical instruments and supplies industry. With a market cap of $3.25 billion, this New..

PTC Therapeutics, Inc. (PTCT) Stock Analysis: Navigating Growth in Rare Disease Biotech with a 6.24% Upside Potential

PTC Therapeutics, Inc. (NASDAQ: PTCT) stands out in the biotechnology sector as a promising player focused on rare disorders. With a market capitalization of $6.23 billion, this US-based company is..

Surgery Partners, Inc. (SGRY) Investor Outlook: Analyzing a 56% Potential Upside Amid Strong Buy Ratings

Surgery Partners, Inc. (NASDAQ: SGRY), a prominent player in the healthcare sector specializing in medical care facilities, presents an intriguing investment opportunity. With a market capitalization of $2.11 billion, the..

Search

Funds

January 13, 2026

Search

Funds

January 13, 2026

FTSE 100

Funds